>
Organization
H. Lundbeck A/S
Topic
All Topics
People
Find news about people
Alumni
Find news on alumni of any org
Industries
Find news on a particular market
Your Contacts
Find news on your contacts
Sign up for free daily alerts on this feed:
By pressing Sign Up, you agree to our Terms of Use, Privacy Policy, and the LexisNexis Terms & Conditions

Follow

Change Feed

News on H. Lundbeck A/S

... H Lundbeck A/S (Lundbeck)(CPH:LUN), a global pharmaceutical company specialised in psychiatric and neurological disorders, ...
... clinical studies. Sojournix acquired SJX-653 through an asset purchase transaction with H. Lundbeck A/S in 2017. Under the terms of the agreement, H. Lundbeck A/S ...
... lure investment. Elsewhere, biotechs posted a mixed set of phase 2 data. Lundbeck and Genfit chalked up successes in PTSD and primary biliary cholangitis, respectively, ...
... will be effective as of 31 December 2018. 'After 19 years at Lundbeck and seven years as Head of RD I have decided to retire, ...
... Research and Development (RD), after 19 years with the company. According to Lundbeck, it has initiated a comprehensive international search to identify the company's next ...
... H. Lundbeck A/S (Lundbeck)0.60). This randomised, double-blind, placebo-and active-controlled ...
... Lundbeck and Otuska's brexpiprazole-sertraline cocktail has hit the mark in a post-traumatic stress ...
... Authority. palo@lundbeck.com Palle Holm Olesen Tel: +45 30 83 24 26 About Lundbeck H. Lundbeck A/S (LUN.CO, LUN DC, HLUYY) is a global pharmaceutical company ...
... H. Lundbeck A/S (Lundbeck) (CPH:LUN), a global pharmaceutical company specialised in psychiatric and neurological ...
... (Jansenn Pharmaceuticals), Banzel (Jansenn Pharmaceuticals) , Lamictal (GlaxoSmithKline), Felbatol (Meda Pharmaceuticals), Onfi (Lundbeck) and Klonopin (Roche) Lennox Gastaut Syndrome Drugs Uptake This section focusses on ...
Subscribe now for full coverage on H. Lundbeck A/S
Start My Free Trial